Abstract
Skeletal muscle has remarkable regenerative ability after injury. Mesenchymal fibro-adipogenic progenitors (FAPs) are necessary, active participants during this repair process, but the molecular signatures of these cells and their functional relevance remain largely unexplored. Here, using a lineage tracing mouse model (Gli1-CreER Tomato), we demonstrate that Gli1 marks a small subset of muscle-resident FAPs with elevated Hedgehog (Hh) signaling. Upon notexin muscle injury, these cells preferentially and rapidly expanded within FAPs. Ablation of Gli1+ cells using a DTA mouse model drastically reduced fibroblastic colony-forming unit (CFU-F) colonies generated by muscle cells and impaired muscle repair at 28 days. Pharmacologic manipulation revealed that Gli1+ FAPs rely on Hh signaling to increase the size of regenerating myofiber. Sorted Gli1+ FAPs displayed superior clonogenicity and reduced adipogenic differentiation ability in culture compared to sorted Gli1− FAPs. In a glycerol injury model, Gli1+ FAPs were less likely to give rise to muscle adipocytes compared to other FAPs. Further cell ablation and Hh activator/inhibitor treatments demonstrated their dual actions in enhancing myogenesis and reducing adipogenesis after injury. Examining single-cell RNA-sequencing dataset of FAPs from normal mice indicated that Gli1+ FAPs with increased Hh signaling provide trophic signals to myogenic cells while restrict their own adipogenic differentiation. Collectively, our findings identified a subpopulation of FAPs that play an essential role in skeletal muscle repair. © 2021 American Society for Bone and Mineral Research (ASBMR).
Funding Information
  • American Heart Association (17GRNT33671042)
  • Muscular Dystrophy Association (MDA-603883)
  • National Aeronautics and Space Administration (18-FG_ind_2-0022)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR066098, R21AR074570)
  • National Institutes of Health (P30 AR069619, R01HL146662-01A1)
  • American Heart Association (17GRNT33671042)
  • Muscular Dystrophy Association (MDA‐603883)
  • National Aeronautics and Space Administration (18‐FG_ind_2‐0022)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR066098, R21AR074570)
  • National Institutes of Health (P30 AR069619, R01HL146662‐01A1)

This publication has 53 references indexed in Scilit: